A research group from ETH Zurich recently reported the generation of a synthetic version of the model bacterium Caulobacter crescentus genome. This work advances our knowledge on synthetic chromosome construction...
The Global
Synthetic Biology Summit
Synthetic Biology Summit
SVN West
San Francisco, California
Tuesday-Thursday, Oct. 1-3, 2019
REGISTER NOW!
The Global
Synthetic Biology Summit
Synthetic Biology Summit
SVN West
San Francisco, California
Tuesday-Thursday, Oct. 1-3, 2019
Stay updated on the latest news in synthetic biology with
LanzaTech Spearheads The Green Tech Revolution
Using an atypical bacterial strain to recycle waste gas into fuel and chemicals, LanzaTech is helping to give the environment a fighting chance.
A two-for-one punch: how Mango Materials turns waste methane into biodegradable materials
“We spend a lot of our time looking at biodegradability in anaerobic environments, marine environments, backyard compost.”
Meet CRISPR’s new small molecule inhibitor
There are several applications that could benefit from CRISPR inhibitors.
The new kids on the block: first-time investors in synthetic biology are focused on cleantech
Cleantech investing has recently emerged from the trough of disillusionment, propelled by new technologies including synthetic biology.
Editors' picks
Meet the 25 synthetic biology companies that raised $652M this quarter
The industry’s Class of 2019 includes many new investors and innovative startups, setting the stage for a strong year The synthetic biology industry got off to a hot start in 2019, with 25 companies raising $652 million...
ActoBio Therapeutics™ CEO Pieter Rottiers on the potential to cure disease with living medicines
With the therapeutic potential of engineered cells, we may be closer than ever to curing diseases like type 1 diabetes With over 1 million Americans living with Type 1 diabetes (T1D), it’s likely that you know someone...
